Reata Pharmaceuticals

Reata Pharmaceuticals

Reata Pharmaceuticals

Reata Pharmaceuticals, Inc. translates innovative science into breakthrough medicines for a broad range of intractable diseases.
Type
B2b
Founded
2002
Raised
$173.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$35,000,000
Post-IPO debt - 2017
Silicon Valley Bank Oxford Finance
$60,500,000
IPO - 2016
Team Size
10+
Employees
$35,000,000 Post-IPO debt
biospace

Reata Pharmaceuticals Inc Secures 35 Million Term Loan Facility